SolGent to export COVID-19 detection kits to US
President Moon Jae-in speaks with representatives of Korean COVID-19 detection kit makers, including SolGent's co-CEO You Jae-hyung, left, at Seegen's office in southern Seoul, Wednesday. YonhapBy Jung Min-hoSolGent, a subsidiary of Korean genome sequencing company EDGC, will export its COVID-19 detection kits to the United States, where cases have been soaring over the past few weeks.SolGent told The Korea Times Thursday that it has signed a letter of intent (LOI) with several U.S. states, including New York, California and Nevada, to sell its kits (DiaPlexQ) for 1 million tests.This comes two days after U.S. President Donald Trump asked Korean President Moon Jae-in during a phone conversation for supplies to help combat the disease. Trump then said he would help expedite the process of receiving approval from the Food and Drug Administration for supply providers.The next day, Moon met representatives of five detection kit makers, including SolGent's co-CEO You Jae-hyung, to thank them for their R&D efforts, saying he was “grateful and proud” of them.SolGent's corona
